Clinical outcome for heart failure hospitalizations in patients with leadless pacemaker

Back

ESC Professional Premium Access

Clinical outcome for heart failure hospitalizations in patients with leadless pacemaker

Session: Devices and outcomes of ventricular arrhythmias

Topic: Device Treatment

Speaker: Doctor M. Nagashima (Fukuoka, JP)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Michio Nagashima

Kokura Memorial Hospital, Fukuoka (Japan)

0 follower

6 more presentations in this session

Permanent pacemaker implantations among patients with spinal cord injury in the United States

Speaker: Doctor G. Margolis (Hadera, IL)

Is there a significant 1-year impact on tricuspid valve regurgitation evolution in leadless-PM implanted subjects?

Speaker: Doctor A. Sabatini (Verona, IT)

Clinical and echocardiographic impact of physiological estimulation in patients with preserved ejection fraction: a randomized clinical trial

Speaker: Mr O. Rodriguez Queralto (Escaldes, AD)

N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: data from the SMASH Study

Speaker: Doctor N. Sourour (Nordbyhagen, NO)

Clinical genetic testing in arrhythmogenic mitral valve prolapse syndrome highlights a potential overlap with familial dilated cardiomyopathy

Speaker: Doctor J. Giudicessi (Rochester, US)

Access the full session

Devices and outcomes of ventricular arrhythmias

Speakers: Doctor M. Nagashima, Doctor G. Margolis, Doctor A. Sabatini, Mr O. Rodriguez Queralto, Doctor N. Sourour...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Clinical outcome for heart failure hospitalizations in patients with leadless pacemaker

About the speaker

Doctor Michio Nagashima

6 more presentations in this session

Permanent pacemaker implantations among patients with spinal cord injury in the United States

Is there a significant 1-year impact on tricuspid valve regurgitation evolution in leadless-PM implanted subjects?

Clinical and echocardiographic impact of physiological estimulation in patients with preserved ejection fraction: a randomized clinical trial

N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: data from the SMASH Study

Clinical genetic testing in arrhythmogenic mitral valve prolapse syndrome highlights a potential overlap with familial dilated cardiomyopathy

Access the full session

Devices and outcomes of ventricular arrhythmias

About the event

ESC Congress 2023

ESC 365 is supported by